期刊文献+

结肠癌中AKT2和HCCR的表达及临床意义 被引量:2

Expression and Its Significance of AKT2 and HCCR in Colorectal Cancer
原文传递
导出
摘要 目的:探讨AKT2与人宫颈癌基因(HCCR)在结肠癌组织中的表达及意义。方法:应用免疫组织化学SP法检测70例结肠癌组织、30例正常结肠组织中AKT2和HCCR的表达,分析HC-CR的表达与临床病理特征的关系。结果:AKT2在30例正常结肠组织中2例阳性表达,表达率为6.7%;在70例结肠癌组织中43例为阳性表达,表达率为61.4%。HCCR在30例正常组织中有1例阳性表达,表达率为6.6%,在70例结肠癌组织中有49例阳性表达,阳性率70.0%,其阳性表达与分化程度、淋巴结转移、Dukes分期有关(P<0.05)。癌组织中AKT2与HCCR的表达呈正相关(r=0.611,n=70,P=0.000)。结论:结肠癌组织中HCCR处于过度表达状态与结肠癌的发生密切相关。AKT2作为癌基因在结肠癌的发生发展中发挥作用,AKT2可能通过PI3K/Akt信号转导通路调节HCCR的表达。 Objective:To explore the expression of AKT2 and HCCR in colorectal carcinoma tissues and its prognostic significance.Methods:The expression of AKT2 and HCCR in 70 samples of colorectal carcinoma tissue and 30 samples of normal colorectal tissue around the foci were detected by SP immunohistochemistry.The relationship between expressions of HCCR and clinic pathological features including prognosis of patients with colorectal carcinoma was analyzed.Results:The positive express of AKT2 in normal group and carcinoma group was 6.7%(2/30) and 61.4%(43/70) respectively.The positive expression of HCCR in normal sample and carcinoma sample was 6.7%(1/30) and 70%(49/70) respectively,and this related to differentiation grade of carcinoma,lymph node metastases and Dukes' stage(P0.05).The positive expression of AKT2 has a positive correlation with HCCR in colorectal carcinoma tissues(r=0.611,n=70,P=0.000).Conclusions:The HCCR stand in over-expression status in the colorectal carcinoma tissues,HCCR could play an important role in the occurrence of colorectal carcinoma.And AKT2 plays a role as a cancer gene in the occurrence of colorectal carcinoma.
出处 《青海医药杂志》 2012年第8期6-9,共4页 Qinghai Medical Journal
关键词 结肠癌 AKT2 HCCR 免疫组化 Colorectal carcinoma AKT2 HCCR Immunohistochemistry
  • 相关文献

参考文献10

  • 1Zur A,Brandeis M. Securin degradation is mediated by fzy and fzr,and is required for complete chromatid separation but not for cytokinesis[J].EMBO Journal,2001,(04):792-801.
  • 2Ishikawa H,Heaney AP,Yu R. Human pituitary tumor-transforming gene induces angiogenesis[J].Journal of Clinical Endocrinology and Metabolism,2001,(02):867-874.
  • 3Ko J,Lee YH,Hwang SY. Identification and differential expression of novel human cervical cancer oncogene HCCR-2 in human cancers and its involvement in p53 stabilization[J].Oncogene,2003,(30):4697-4689.
  • 4Chung YJ,Kim JW. Novel oncogene HCCR:its diagnostic and therapeutic implications for cancer[J].Histology and Histopathology,2005,(03):999-1003.
  • 5Vivanco I,Sawyers CL. The phosphatidylinositol 3-kinase AKT pathway in human cancer[J].Nature Reviews Cancer,2002,(07):489-501.
  • 6Brognard J,Clark AS,Ni Y. Akt/protein kinase B isconstitutively active in non-small-cell lung cancer cells and promotes cellular survival and resistance to chemotherapy and radiation[J].Cancer Research,2001,(10):3986-3997.
  • 7Tsao AS,Mc Donnell T,LamS. Increased phospho-AKT(Ser473)expression in bronchial dysplasia:implications for lung cancer prevention studies[J].Cander Epidemiol Biomark Prey,2003,(07):660-664.
  • 8Yoon SK,Lim NK,Ha SA. The Human cervicalcancer oncogene protein is a biomarker for human hepatocellular carcinoma[J].Cancer Research,2004,(15):5434-5441.
  • 9Ko J,Shin SM,Oh YM. Transgenic mouse model foebreast cancer:induction of breast cancer in novel oncogeneHCCR-2transgenic mice[J].Oncogene,2004,(10):1950-1951.
  • 10Fayard E,Tintignac LA,Baudry A. Protein kinase B/Akt at aglance[J].Journal of Cell Science,2005,(24):5675-5678.

同被引文献28

  • 1董涛,金伟,刘福国,许建民,周洪美,栾春艳.结肠癌组织中PTEN、AKT2、HIF-1α的表达变化及意义[J].山东医药,2010,50(50):43-44. 被引量:1
  • 2夏剑波,张振华,田拥军,孟忠吉,喻植群,赵西平,杨东亮.肝癌新标志物人宫颈癌基因的克隆、原核表达及多克隆抗体的制备[J].中华肝脏病杂志,2006,14(2):101-104. 被引量:5
  • 3Zur A, Brandeis M.Securin degradation is mediated byfzy and fzr,and is required for complete chromatid separation butnot for cytokinesis[J].EMBO J,2001,20(4) :792-801.
  • 4Ishikawa H, Heaney AP’Yu R,et al.Human pituitarytumor-transforming gene induces angiogenesis [ J ]. J Clin Endo-crinol Metab,2001,86(2) ;867-874.
  • 5KoJ,LEE YH, HWANG SY,et al.Identification anddifferential expression of novel human cervical cancer oncogeneHCCR-2 in human cancers and its involvement in p53 stabiliza-tion[J].Oncogene,2003,22(30) :4697-4689.
  • 6CHUNG YJ,KIM JW.Novel oncogene HCCR:its diag-nostic and therapeutic implications for cancer [ J ]. Histol his-topathol.2005,20(3) :999-1003.
  • 7Ambrosini G,Adida C, Altieri DC’et al.A novel anti-apoptosis gene, Survivin, expression in cancer and lymphoma[J].Nat Med,1997,3(8) :917-921.
  • 8JirunP,Zhang G,Ha SA,et al.HCCR-1 for detectingsmall hepatocellular carcinoma latent in a cirrhotic live : a pro-spective cohort study[J] .Gut,2012,61( 10) : 1514-1515.
  • 9Yoon SK,Iim NK, Ha SA, et al.The Human cervicalcancer oncogene protein is a biomarker for human hepatocellularcarcinoma[J] .Cancer Res,2004, 64( 15) : 5434-5441.
  • 10KoJ,Shin SM,Oh YM,et al.Transgenic mouse modelfoe breast cancer: induction of breast cancer in novel oncogeneHCCR-2 transgenic mice[ J].Oncogene,2004,23( 10) : 1950-19.

引证文献2

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部